Rolke James 4
4 · REVELATION BIOSCIENCES, INC. · Filed Feb 28, 2023
Insider Transaction Report
Form 4
Rolke James
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-25+2,542→ 0 totalExercise: $49.00Exp: 2032-02-25→ Common Stock (2,542 underlying)
Footnotes (1)
- [F1]The stock options were granted on 2/25/2022 and vest 25% on the one-year anniversary of the grant date, and thereafter quarterly over a three-year period, subject to continued service through each such vesting date.